|
|
Profile
|
Delegates :
President Tsutomu Seito |
|
Incorporated :
September 9 , 1982 |
Paid in Capital :
1571 Million yen |
Employees :
59 人 |
Address :
1091-1 Naka Aza-Higashida, Fujioka-Shi, Gunma 375-0005, JAPAN GUNMA
〒375-0005
|
TEL/FAX :
+81-274-22-2889 / +81-274-23-6055 |
URL：
http://www.ibl-japan.co.jp/ |
Attachment :
|
Mission/Background :
Our main business is developing and marketing quantitative assays by immuno-enzymatic techniques using our developed antibodies. These advanced diagnostic products are marketed throughout the world and our reputation for quality and service is highly renowned.
Recently, we incorporated a new technology for producing recombinant proteins including monoclonal antibodies using silkworms. We are aiming to use this technology for producing various products including therapeutic agents.
|
|
Technology & Business
|
We possess technologies for "high level expression of recombinant proteins in cocoons of transgenic silkworms". The recombinant proteins are extractable from the cocoons under the condition where most of cocoon proteins remain insoluble. This technology allows us to obtain the recombinant proteins with little amount of contaminated cocoon proteins, making it simple to purify them. Using this technology, we have successfully produced various recombinant proteins including fibrinogen, antibody, collagen (gelatin), serum albumin, growth hormone, growth factors and cytokines.
|
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
Various ELISA Kits
|
Launched
|
We developed and launched various ELISA kits for reserch and diagnostic uses.
|
Development of new products
|
Production of antibodies for diagnositic uses in transgenic silkworms
|
Launched
|
Silkworms are free from ethical problem, and can be best solution as a substitute for mouse ascites antibody production.
|
Increases in sale
|
Human collagen as a novel cosmetic ingredient
|
Launched
|
Collagen produced by silkworms is human-type, and can be used as a low allergenic safe and comfortable material.
|
Increases in sale
|
Production of pharmaceuitical proteins in transgenic silkworms
|
Discovery
|
We are developing pharmaceuitical proteins including fibrinogen, antibodies and vaccines using transgenic silkworms.
|
Alliance with pharmaceutical companies
|
|
|
|
|
|
Highlights
|
We showed the usability of recombinant antobodies prodeced by silkworms as reagents for reseach and diagnostic uses, and are preparing to launch human collgen in cosmetic uses. Recently, we also demonstrated the production of recombinant fibrinogen with hemostatic activity.
|
|
Hot news
|
We obtained INCI name for Human Collagen.
Product name: Neosilk-Human Collagen I
INCI name: Transgenic Silkworm rh-Polypeptide-47
|
|
Alliance strategy
|
We hope alliances with pharmaceutical, diagnostic agents, and cosmetic companies for applications of recombinant proteins including antibodies, fibrinogen, vaccines, and collagen.
|
|
|